CLDI

1.02% 0.0017

Handel nachbörslich: .18 0.0025 +1.41%

Calidi Biotherapeutics Inc (CLDI)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Calidi Biotherapeutics Inc

Healthcare (1113)

Biotechnology (618)

(858) 794-9600

4475 Executive Drive, Suite 200, San Diego

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CLDI's Discussions on Twitter

Compare CLDI vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CLDI Calidi Biotherapeutics Inc	0.1775	3.39M	0	-25.74M	-21.41M	-4.938
VRTX Vertex Pharmaceuticals Inc	435.92	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.42	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.61	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-11-22	Eingeleitet	H.C. Wainwright	Buy
2023-10-09	Eingeleitet	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Calidi Biotherapeutics Inc (CLDI)

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Compare CLDI vs VRTX, REGN, ARGX, ALNY, RVMD

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Calidi Biotherapeutics Inc Aktie (CLDI) Neueste Nachrichten

Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting - Weekly Voice

Tumor-targeting virotherapy from Calidi to appear at 2026 ASCO - Stock Titan

Calidi Biotherapeutics Q4 2025 Earnings: Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline - Newser

Calidi Biotherapeutics Provides Required NYSE American Disclosure - The Manila Times

Calidi Biotherapeutics discloses NYSE-required audit note on going concern status in 2025 financial report. - Pluang

Calidi Biotherapeutics, Inc. Issues Financial Statement Audit Report Highlighting Going Concern Assumption - Quiver Quantitative

Biotech Calidi’s 2025 audit report includes 'going concern' note - Stock Titan

Armistice Capital (CLDI) reports 1.11M shares, 9.99% ownership - Stock Titan

Calidi Highlights Q1 Results and RedTail Platform Progress - TipRanks

Calidi Biotherapeutics 1Q 2026: Net loss $4.42M, EPS $(0.43) — 10-Q Summary - TradingView

Calidi Biotherapeutics (CLDI) Q1 2026 loss, cash runway and warrant overhang detailed - Stock Titan

Calidi Biotherapeutics (NYSE: CLDI) Q1 2026 loss narrows as cash rises - Stock Titan

Biotech Calidi cuts costs, taps AI partner for CLD-401 IND - Stock Titan

Press Release: Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights - Moomoo

Calidi Biotherapeutics Confirms Featured Speaker Presentation Tomorrow at the ASGCT Conference in Boston - GlobeNewswire

TradingKey - TradingKey

How Calidi (CLDI) maintains its competitive edge | Q4 2025: Better Than ExpectedFree Cash Margin - Newser

Calidi Biotherapeutics, Inc. Files Form 8-K for Material Definitive Agreement and Common Stock Purchase Warrants – SEC Filing May 6, 2026 - Minichart

Calidi Biotherapeutics Issues Private Placement Warrant Financing - TipRanks

Calidi Biotherapeutics Issues Warrant for 17.4M Shares, Linked to Up to $4M Stock Buys at $0.23 - TradingView

Calidi Biotherapeutics (CLDI) grants 17.4M-share warrant linked to $4M equity - Stock Titan

Calidi Biotherapeutics announces underwritten public offering - Investing.com

CLDI Stock Price, Quote & Chart | CALIDI BIOTHERAPEUTICS INC (NYSEARCA:CLDI) - ChartMill

DEFA14A: Others - Moomoo

Calidi Biotherapeutics (CLDI) sets vote on reverse split and larger equity plan - Stock Titan

Calidi Biotherapeutics announces strategic partnership with Transferai - marketscreener.com

Calidi partners with TransferAI for CLD-401 regulatory filing By Investing.com - Investing.com South Africa

Calidi partners with TransferAI for CLD-401 regulatory filing - Investing.com

Calidi Biotherapeutics Announces Strategic Partnership With Transferai - TradingView

Calidi turns to AI software as it pushes CLD-401 toward filing - Stock Titan

Calidi (CLDI) Stock: Breakout Potential Analysis | Q4 2025: Better Than ExpectedVerified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai

CLDI (Calidi Biotherapeutics Inc.) posts 73.6% positive Q4 2025 EPS surprise, shares edge slightly lower in today’s trading.Revenue Diversification - Cổng thông tin điện tử tỉnh Lào Cai

Calidi Biotherapeutics Presents New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026 - marketscreener.com

Calidi says CLD-401 drove tumor immune response ahead of 2026 IND - Stock Titan

Calidi presents cancer therapy data at AACR meeting By Investing.com - Investing.com India

Certain Stock Options of Calidi Biotherapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-APR-2026. - marketscreener.com

Calidi (CLDI) Stock Futures Trade (Trend Weakens) 2026-04-20Price Target - Cổng thông tin điện tử tỉnh Lào Cai

Calidi presents cancer therapy data at AACR meeting - Investing.com

Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 - The Manila Times

Calidi targets a hard cancer marker with tumor-restricted engager - Stock Titan

Calidi Biotherapeutics (CLDI) seeks approval for reverse split, 1.95M-plan increase - Stock Titan

Calidi Biotherapeutics Streamlines Board, Enhances Audit Oversight - TipRanks

Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - Sahm

Calidi Biotherapeutics to Showcase Advances in Virotherapy at RedChip's Virtual Investor Conference on April 16, 2026 - Quiver Quantitative

Calidi Biotherapeutics Announces Participation in RedChip’s April 16 Virtual Investor ... - Caledonian Record

Calidi Biotherapeutics Announces Participation in RedChip’s - GlobeNewswire

Finanzdaten der Calidi Biotherapeutics Inc-Aktie (CLDI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CLDI